Redesign of aminoglycosides for treatment of human genetic diseases caused by premature stop mutations

被引：65
|
作者：
Nudelman, Igor
Rebibo-Sabbah, Annie
Shallom-Shezifi, Dalia
Hainrichson, Mariana
Stahl, Ido
Ben-Yosef, Tamar [1 ]
Baasov, Timor
机构：
[1] Technion Israel Inst Technol, Dept Genet, Fac Med, IL-31096 Haifa, Israel
[2] Technion Israel Inst Technol, Rappaport Family Inst Res Med Sci, IL-31096 Haifa, Israel
[3] Technion Israel Inst Technol, Edith & Joseph Fischer enzyme Inhibitors Lab, Dept Chem, Inst Catalysis Sci & Technol, IL-32000 Haifa, Israel
来源：
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2006年 / 16卷 / 24期
基金：
以色列科学基金会;
关键词：
aminoglycosides; cystic fibrosis; drug design; stop mutation suppression; Usher syndrome;
D O I：
10.1016/j.bmcl.2006.09.013
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
A series of new derivatives of the clinically used aminoglycoside antibiotic paromomycin were designed, synthesized, and their ability to read-through premature stop codon mutations was examined in both in vitro translation system and ex vivo mammalian cultured cells. One of these structures, a pseudo-trisaccharide derivative, showed notably higher stop codon read-through activity in cultured cells compared to those of paromomycin and gentamicin. (c) 2006 Elsevier Ltd. All rights reserved.
引用
收藏
页码：6310 / 6315
页数：6
相关论文
共 50 条
  • [21] Structural Basis for Mutations of Human Aquaporins Associated to Genetic Diseases
    Calvanese, Luisa
    D'Auria, Gabriella
    Vangone, Anna
    Falcigno, Lucia
    Oliva, Romina
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2018, 19 (06):
  • [22] Laminopathies; Mutations on single gene and various human genetic diseases
    Kang, So-mi
    Yoon, Min-Ho
    Park, Bum-Joon
    BMB REPORTS, 2018, 51 (07) : 327 - 337
  • [23] The Growing Spectrum of Human Diseases Caused by Inherited CDC42 Mutations
    Su, Helen C.
    Orange, Jordan S.
    JOURNAL OF CLINICAL IMMUNOLOGY, 2020, 40 (04) : 551 - 553
  • [24] Quantitative mapping of genetic similarity in human heritable diseases by shared mutations
    Zhao, Huiying
    Yang, Yuedong
    Lu, Yutong
    Mort, Matthew
    Cooper, David N.
    Zuo, Zhiyi
    Zhou, Yaoqi
    HUMAN MUTATION, 2018, 39 (02) : 292 - 301
  • [25] How similar are amino acid mutations in human genetic diseases and evolution
    Wu, Hao
    Ma, Bin-Guang
    Zhao, Ji-Tao
    Zhang, Hong-Yu
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2007, 362 (02) : 233 - 237
  • [26] Human Genetic Predisposition to Diseases Caused by Viruses from Flaviviridae Family
    N. S. Yudin
    A. V. Barkhash
    V. N. Maksimov
    E. V. Ignatieva
    A. G. Romaschenko
    Molecular Biology, 2018, 52 : 165 - 181
  • [27] Human Genetic Predisposition to Diseases Caused by Viruses from Flaviviridae Family
    Yudin, N. S.
    Barkhash, A. V.
    Maksimov, V. N.
    Ignatieva, E. V.
    Romaschenko, A. G.
    MOLECULAR BIOLOGY, 2018, 52 (02) : 165 - 181
  • [28] Effect of Readthrough Treatment in Fibroblasts of Patients Affected by Lysosomal Diseases Caused by Premature Termination Codons
    Leslie Matalonga
    Ángela Arias
    Frederic Tort
    Xènia Ferrer-Cortés
    Judit Garcia-Villoria
    Maria Josep Coll
    Laura Gort
    Antonia Ribes
    Neurotherapeutics, 2015, 12 : 874 - 886
  • [29] Development of generic immunoassay for the detection of a series of aminoglycosides with 6′-OH group for the treatment of genetic diseases in biological samples
    Shalev, Moran
    Kandasamy, Jeyakumar
    Skalka, Nir
    Belakhov, Valery
    Rosin-Arbesfeld, Rina
    Baasov, Timor
    JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2013, 75 : 33 - 40
  • [30] Effect of Readthrough Treatment in Fibroblasts of Patients Affected by Lysosomal Diseases Caused by Premature Termination Codons
    Matalonga, Leslie
    Arias, Angela
    Tort, Frederic
    Ferrer-Cortes, Xenia
    Garcia-Villoria, Judit
    Coll, Maria Josep
    Gort, Laura
    Ribes, Antonia
    NEUROTHERAPEUTICS, 2015, 12 (04) : 874 - 886
12345